C2i Genomics
Latest round
- Series B
Last raised
- Apr 2021
Total raised
- $112M
Investors
- 10
About C2i Genomics
Based in New York, US, and founded in 2019, C2i Genomics, Inc. operates as a healthcare company that provides cloud-based cancer diagnostic solutions for pharmaceutical and diagnostic sectors. The company was founded by Asaf Zviran, Boris Oklander, Dan Landau, and Ezra Sofer. In January 2024, Veracyte Inc. agreed to acquire C2i Genomics, Inc. from Casdin Capital, NFX, The Mark Foundation for Cancer Research, Alexandria Venture Investments, Driehaus Capital Management LLC, Duquesne Family Office, iGlobe Partners, LionBird, Section 32, and Silver Lake for USD 95 million. The company provides a Saas platform that uses AI pattern recognition and whole-genome analysis that helps physicians to detect treatment failure and monitor patient treatment response.
Who invested in C2i Genomics
10 investors across 2 rounds
See all investors in C2i Genomics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about C2i Genomics
Who invested in C2i Genomics?
C2i Genomics has 10 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has C2i Genomics raised?
C2i Genomics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did C2i Genomics last raise money?
C2i Genomics's most recent round on record is a Series B, in Apr 2021.
What does C2i Genomics do?
Based in New York, US, and founded in 2019, C2i Genomics, Inc.
Where is C2i Genomics headquartered?
C2i Genomics is headquartered in New York, US.
Which VCs invest in companies like C2i Genomics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare it companies at C2i Genomics's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series B
Raising like C2i Genomics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.